Project Grant HT9425261E067
Award Date 4/1/26
Completion Date 3/31/29
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded La Trobe University a Project Grant of $669,102 under the Military Medical Research and Development program (CFDA 12.420) for the period April 1, 2026 through March 31, 2029. The project, "Using Novel Biological Therapies to Target a Tumor-Specific Isoform of HER2 for the Treatment of Advanced Breast Cancer," supports advanced biomedical research aimed at developing innovative therapeutic interventions for breast...
- Federal Project Grant Award Summary The University of Melbourne has been awarded $721,656 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, with a completion date of October 31, 2028. The award supports a three-year research project focused on minimally-invasive measurement of pressure dynamics in the brain following traumatic brain injury (TBI). This research initiative aligns with the DHA's commitment to...
- The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...
- Federal Grant Award Summary The University of Queensland received a $563,707 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports research to develop predictive multiomics profiling methodologies for identifying early-stage melanoma cases at elevated risk of recurrence. This research directly aligns with the DHA's mission to advance biomedical solutions...
- Federal Grant Award Summary The University of Queensland has been awarded $1,156,726 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research project spanning September 1, 2025, through August 31, 2028. The project, titled "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling," focuses on developing innovative diagnostic capabilities to identify melanoma patients at...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The University of Queensland (UQ) a Project Grant totaling $506,785 under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2028. The research project, titled "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling," focuses on developing advanced diagnostic methodologies to identify melanoma patients at elevated...
- The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...
- This $1,072,784 federal Project Grant was awarded on May 1, 2024 by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to the University of Melbourne (Australia) to conduct research aimed at "IMPROVING OVARIAN CANCER OUTCOMES BY UNDERSTANDING AND TARGETING ACQUIRED RESISTANCE." The research project is scheduled for completion on April 30, 2028. The University of Melbourne has a history of successfully delivering...
- The University of Melbourne was awarded a $768,263 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on developing a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer. The goal of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions. This award will...